<Record>
<Term>Mustard Prodrug</Term>
<SemanticType>Pharmacologic Substance</SemanticType>
<ParentTerm>Mustard Agent</ParentTerm>
<ClassificationPath>Chemicals_and_Drugs_Kind/Drug, Food, Chemical or Biomedical Material/Pharmacologic Substance/Antineoplastic Agent/Alkylating Agent/Antineoplastic Alkylating Agent/Mustard Agent/Mustard Prodrug</ClassificationPath>
<BroaderTerm>Mustard Prodrug</BroaderTerm>
<BroaderTerm>Chemicals_and_Drugs_Kind</BroaderTerm>
<BroaderTerm>Antineoplastic Agent</BroaderTerm>
<BroaderTerm>Pharmacologic Substance</BroaderTerm>
<BroaderTerm>Mustard Agent</BroaderTerm>
<BroaderTerm>Antineoplastic Alkylating Agent</BroaderTerm>
<BroaderTerm>Alkylating Agent</BroaderTerm>
<BroaderTerm>Drug, Food, Chemical or Biomedical Material</BroaderTerm>
<ChildTerm>ZD2767</ChildTerm>
<ChildTerm>TLK286</ChildTerm>
<Synonym>Mustard Prodrug</Synonym>
<Description>An agent when activated is converted into an active mustard alkylating agent at the tumor site, causing DNA cross-linking.  These compounds may be used in antibody-directed enzyme prodrug therapy (ADEPT).</Description>
<Source>NCI Thesaurus</Source>
</Record>
